本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Cellectis S.A.

1.54
+0.01000.65%
盘后1.540.00000.00%16:38 EDT
成交量:6.18万
成交额:9.51万
市值:1.54亿
市盈率:-3.76
高:1.57
开:1.54
低:1.51
收:1.53
数据加载中...

公司资料

公司名字:
Cellectis S.A.
交易所:
NASDAQ
成立时间:
1999
员工人数:
219
公司地址:
8 rue de la Croix Jarry,Paris,Ile-de-France,France
邮编:
75013
传真:
33 1 81 69 16 06
简介:
Cellectis S.A.于2000年1月4日成立。该公司是一家处于临床阶段的生物技术公司,利用他们的核心专有技术开发基于基因编辑的产品,拥有一系列同种异体嵌合抗原受体T细胞,即免疫肿瘤学领域的候选产品和基因编辑造血干细胞和祖细胞,即HSPC,其他治疗适应症的候选产品。

董事

名称
职位
Andre Choulika
Director, Chief Executive Officer and Co-Founder
Jean Pierre Garnier
Chairman of the Board and Director
David Sourdive
Director, Executive Vice President, Strategic Initiatives and Co-Founder
Alain Godard
Director
Annick Schwebig
Director
Herve Hoppenot
Director
Laurent Arthaud
Director
Pierre Bastid
Director
Rainer Boehm
Director

股东

名称
职位
Andre Choulika
Director, Chief Executive Officer and Co-Founder
Eric Dutang
Chief Financial Officer
Leopold Bertea
Senior Vice President of Europe Technical Operations
Steven Doares
Senior Vice President of US Manufacturing
Arthur Stril
Chief Business Officer
Carrie Brownstein
Chief Medical Officer
David Sourdive
Director, Executive Vice President, Strategic Initiatives and Co-Founder
Jon Voss
Executive Vice President Global Quality
Kyung Nam Wortman
Chief Human Resources Officer
Marie Bleuenn Terrier
General Counsel
Philippe Duchateau
Chief Scientific Officer
Stephan Reynier
Chief Regulatory,Pharmaceutical Compliance Officer